Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 05, 2021

Reduced MACE and Limb Events in Patients With Diabetes Treated With GLP1RAs vs DPP4is



Additional Info

Major Adverse Cardiovascular and Limb Events in Patients With Diabetes Treated With GLP-1 Receptor Agonists vs DPP-4 Inhibitors
Diabetologia 2021 Sep 01;64(9)1949-1962, DS Lin, JK Lee, WJ Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading